Experienced oncology nurses and APPs can help nurses newer to the field understand who is more at risk of opioid addiction, ...

Panelists discuss how the unprecedented 5-year progression-free survival benefit (60% vs 8%) demonstrated in the CROWN trial ...

Adding sonrotoclax to zanubrutinib led to deep and durable response in relapsed or refractory mantle cell lymphoma, according ...

Explore essential mental health support strategies for older adults with cancer, addressing grief, community resources, and ...

Panelists discuss that talquetamab dose modifications are guided primarily by patient symptoms and adverse effects, with ...

Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient-centered cancer care.

ICE-T Conference presenters explain what nurses and APPs should take into account as immune cell effector therapies become ...

Hope S. Rugo, MD, FASCO, emphasized the importance of educating patients about proactive rash and diarrhea management while taking PI3K/AKT inhibitors.

Panelists discuss City of Hope’s multidisciplinary approach, highlighting pharmacists providing medication guidance, social ...

Panelists share that despite initial emotional challenges, multiple myeloma treatment with targeted combination therapies was ...

A generic version of ibrutinib was granted tentative approval by the FDA for use in CLL and SLL with 17p deletion and ...